Presence of Specific 11C-meta-Hydroxyephedrine Retention in Heart, Lung, Pancreas, and Brown Adipose Tissue
Key result
HED exhibits norepinephrine-responsive uptake in lung, pancreas, and brown fat with ~94% unchanged radioactivity.
Population
Male Sprague-Dawley rats
Design
Preclinical
Follow-up
30 minutes
Authors
Discussion
Loading...
Member takes
Implication
Animal data extend HED PET to sympathetic imaging in lung, pancreas, and BAT; leaves open human translation.
Structured PICO
P
Population
Male Sprague-Dawley rats evaluated for 11C-meta-Hydroxyephedrine retention in various tissues.
I
Intervention
11C-meta-Hydroxyephedrine (HED) administration, with or without pretreatment with NET inhibitors, subcutaneous norepinephrine infusion, or monoamine oxidase inhibition
O
Outcome
NET-specific retention of HED and presence of radiolabeled metabolitessurrogate
11C-meta-Hydroxyephedrine exhibits specific and norepinephrine-responsive uptake in the lung, pancreas, and brown adipose tissue, suggesting its potential for PET imaging of sympathetic nervous system integrity in these extracardiac tissues.
Cite This Study
Thackeray et al. (2007) studied this question. 11C-meta-Hydroxyephedrine (HED) was evaluated on NET-specific retention and presence of radiolabeled metabolites. In addition to the heart, the lung, pancreas, and brown adipose tissue exhibit specific and norepinephrine-responsive uptake of HED, with 93%-95% of radioactivity derived from unchanged HED.